Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 602.11M P/E - EPS this Y -28.30% Ern Qtrly Grth -
Income -123.44M Forward P/E -3.74 EPS next Y -15.80% 50D Avg Chg 31.00%
Sales 33.11M PEG -0.08 EPS past 5Y - 200D Avg Chg 10.00%
Dividend N/A Price/Book 1.56 EPS next 5Y 14.50% 52W High Chg -46.00%
Recommedations 1.90 Quick Ratio 8.55 Shares Outstanding 90.36M 52W Low Chg 78.00%
Insider Own 9.93% ROA -24.49% Shares Float 81.46M Beta 2.29
Inst Own 62.76% ROE -42.57% Shares Shorted/Prior 11.63M/11.52M Price 7.06
Gross Margin -289.97% Profit Margin - Avg. Volume 3,073,053 Target Price 15.63
Oper. Margin -1,255.80% Earnings Date - Volume 1,542,529 Change -3.42%
About Caribou Biosciences, Inc.

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. Its lead product candidate is CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma. The company also develops CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Caribou Biosciences, Inc. News
11/20/24 Caribou Biosciences to Participate in Upcoming Investor Conferences
11/10/24 Caribou Biosciences, Inc. (NASDAQ:CRBU) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
11/08/24 Caribou Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
11/06/24 Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags Revenue Estimates
11/06/24 Caribou Biosciences Reports Third Quarter 2024 Financial Results and  Provides Business Update
10/31/24 Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock?
09/25/24 Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024
09/18/24 With 60% ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) boasts of strong institutional backing
09/03/24 Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML
08/12/24 Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
08/08/24 Caribou Biosciences Second Quarter 2024 Earnings: Beats Expectations
08/06/24 Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Tops Revenue Estimates
08/06/24 Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
08/06/24 Caribou Biosciences, Inc. (CRBU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
07/17/24 Caribou lays off staff; Roche walks away from Relay
07/16/24 Is Caribou Biosciences (NASDAQ:CRBU) In A Good Position To Deliver On Growth Plans?
07/09/24 Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
06/03/24 Top Midday Decliners
06/02/24 Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
05/30/24 Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
CRBU Chatroom

User Image lonelywarrior Posted - 20 hours ago

$CRBU Buying into XBI weakness is a good opportunity here, particularly below 1.90 and around 1.80 if it gets there.

User Image Portfoliovalue1 Posted - 1 day ago

$CRBU just opened my position on this baby yesterday!

User Image Windytimes Posted - 1 day ago

$CRBU I see at lease 3.5 by Jan 1st then to 5 if it get momentum then to 7.5 if results are good. To 1.20 if the results aren’t good.

User Image Enkky Posted - 2 days ago

$CRBU if this gets to 1.5 a share, I’ll buy.

User Image IwannaRetire Posted - 3 days ago

@Sandpiper22 $CRBU ... Rachel and Ruhi need a commercial strategy ... We are priced as if there will never be a single dollar coming in... I have been here since the ATH, have DCA all the way down... Focus now needs to be on go to market. Look at NTLA and others who are above $1B, it's because their leadership treats them as publicly traded companies not as UC Berkeley science labs experimenting and tinkering. Rachel is a smart scientist and even she initially missed HLA even though that's been known for years in Stem Cells. Her science skills don't necessarily translate into business acumen. It's time for the board of directors to hire a commercially minded CEO.

User Image Sandpiper22 Posted - 5 days ago

$CRBU https://www.linkedin.com/posts/caribou-biosciences_acr24-lupusnephritis-lupus-activity-7263579418592210944-jBve?utm_source=share&utm_medium=member_ios

User Image PuffyPeter Posted - 5 days ago

$CRBU buddy Bou.. please behave 😬❤️🙌

User Image Rainsjd Posted - 6 days ago

$CRBU https://investor.cariboubio.com/sec-filings/sec-filing/sc-13ga/0000932471-24-000855 Greaaaaaaaaaaat…

User Image Jidane Posted - 6 days ago

$CRBU Point72 shares of caribou biosciences decreased to 2,235,525 shares from around 4,100,000 shares.

User Image Jidane Posted - 6 days ago

$CRBU Avidity partners management LP disposed the whole of their CRBU shares in 3Q.

User Image ebodonicus Posted - 1 week ago

$CRBU god damn this game is not for the faint of heart.

User Image ISEEITALLTHETIME Posted - 1 week ago

$CRBU This was trading in the $2.80's three days ago and now it's $2.04. What ever the reason for the delayed data release, it must be bad.

User Image Windytimes Posted - 1 week ago

$CRBU too comical

User Image biochirp Posted - 1 week ago

$CRBU round trip

User Image CLEMENZA617 Posted - 1 week ago

$ADA.X $SHIB.X $CRBU ok boys n girls, my pay check hits my direct deposit in 1 hour and 6 minutes... CARDANO SHIBA AND CARIBOU BIO for 1200 ALEX!!!

User Image OverTheShoulderBagHolder Posted - 1 week ago

$CRBU 💎🏀🏀

User Image lonelywarrior Posted - 1 week ago

$CRBU Yesterday's selloff was due to XBI bloodbath and due to high beta + still relatively low price. Large moves in both directions. Back to the sky.

User Image PuffyPeter Posted - 1 week ago

$CRBU come on Bou 🙌

User Image BarneyR Posted - 1 week ago

$CRSP $BEAM $NTLA $CRBU $VERV Been waiting for interest rates to come down. The market started to reward our patience with the promise of lower interest rates. Hold on, Barrons and other outlets were called to sound the alarm about Trump's plans and how it'll slow down Fed actions, make them think twice. Thanks Donny, we can see what a great affect you're going to have on the economy. Let's make sure you talk more about deporting our labor workforce, implementing cross the board tariffs and spiking the debt ceiling with corporate tax cuts. Those who voted you in will be the first and most affected. Hard lessons on the way. Look at what happened to the market today, and all they said was how Trump's plans might affect the fed. No one mentioned recession. There's a long way to fall if markets get jittery.

User Image postless Posted - 1 week ago

$CRBU a bit overdone? No?

User Image biochirp Posted - 1 week ago

$CRBU

User Image dkm2222 Posted - 1 week ago

$CRBU almost getting on margins to add more. Really cheap

User Image CLEMENZA617 Posted - 1 week ago

$CRBU $CRNC $SHIB.X $ADA.X CARDANO FOUNDER scheduled to be on the JOE ROGAN PODCAST coming up!!!

User Image CLEMENZA617 Posted - 1 week ago

$CRBU if this ever gained watchers and the volume was 10x this would pull a short squeeze.. HOLD

User Image Windytimes Posted - 1 week ago

$CRBU and just like that a sliver of questionable news and we slide. I don’t really know if pushing CB-011 to 1H with aggressive lymphodepletion treatment is a bad thing, they saw something that pushed this decision, if they saw no efficacy they would have said something.

User Image Windytimes Posted - 1 week ago

$CRBU do we have a sense of any analysts had any input after the earnings call?

User Image jaguarofwallstreet Posted - 1 week ago

$CRBU should this retract back to $2.30? What’s going on next week with this?

User Image Stocksrunner Posted - 1 week ago

$NINE $CRBU $CLNE $ADV $ARAY all hit their LOWEST points today but powered through to CLOSE HIGHER! 🚀📈watch out for more action! 🔥

User Image Profitfire Posted - 1 week ago

$CRBU almost 100% gain 🖐️ $INBS should next

User Image n3logn Posted - 1 week ago

$CRBU

Analyst Ratings
HC Wainwright & Co. Buy Sep 3, 24
HC Wainwright & Co. Buy Aug 14, 24
RBC Capital Outperform Aug 7, 24
HC Wainwright & Co. Buy Jul 17, 24
HC Wainwright & Co. Buy Jun 4, 24
Truist Securities Buy May 16, 24
HC Wainwright & Co. Buy May 13, 24
HC Wainwright & Co. Buy Mar 19, 24
RBC Capital Outperform Mar 12, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Haurwitz Rachel E. President and CEO President and CEO Mar 20 Option 2.96 10,000 29,600 30,000 03/22/23
Kanner Steven Chief Scientific Off.. Chief Scientific Officer Dec 02 Option 2.69 21,401 57,569 323,460 12/02/22
Kanner Steven Chief Scientific Off.. Chief Scientific Officer Aug 25 Option 2.69 43,248 116,337 345,307 08/26/22
Kanner Steven Chief Scientific Off.. Chief Scientific Officer Aug 25 Sell 11.22 43,248 485,243 302,059 08/26/22
Kanner Steven Chief Scientific Off.. Chief Scientific Officer May 13 Option 2.25 74,420 167,445 302,059 05/17/22
Haurwitz Rachel E. President and CEO President and CEO May 09 Option 2.96 10,000 29,600 20,000 05/10/22
Haurwitz Rachel E. President and CEO President and CEO Jan 26 Option 2.96 10,000 29,600 10,000 05/10/22
Fischesser Ryan VP of Finance and Co.. VP of Finance and Controller May 05 Option 3.4 2,274 7,732 115,518 05/06/22
Fischesser Ryan VP of Finance and Co.. VP of Finance and Controller Mar 15 Option 3.4 2,274 7,732 113,244 03/17/22
Kanner Steven Chief Scientific Off.. Chief Scientific Officer Mar 04 Option 3.4 10,720 36,448 227,639 03/07/22
O'Byrne Jason Chief Financial Offi.. Chief Financial Officer Feb 08 Option 4.11 24,336 100,021 24,336 02/08/22
Fischesser Ryan VP of Finance and Co.. VP of Finance and Controller Jan 11 Buy 3.4 7,387 25,116 109,082 01/12/22
MCCLUNG BARBARA G Chief Legal Officer Chief Legal Officer Oct 20 Buy 2.69 9,219 24,799 342,844 10/21/21
Kanner Steven Chief Scientific Off.. Chief Scientific Officer Oct 12 Buy 2.1 114,860 241,206 215,031 10/13/21